Clinical Trial Update: Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing delayed or standard tacrolimus (Prograf) with induction therapy followed by conversion to extended-release tacrolimus (A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma China, Inc. | Conditions: Kidney Transplant | Phase 4 | Status: COMPLETED